Advances in single-cell RNA sequencing and its applications in cancer research
D Huang, N Ma, X Li, Y Gou, Y Duan, B Liu… - Journal of hematology & …, 2023 - Springer
Cancers are a group of heterogeneous diseases characterized by the acquisition of
functional capabilities during the transition from a normal to a neoplastic state. Powerful …
functional capabilities during the transition from a normal to a neoplastic state. Powerful …
Senescent CAFs mediate immunosuppression and drive breast cancer progression
The tumor microenvironment (TME) profoundly influences tumorigenesis, with gene
expression in the breast TME capable of predicting clinical outcomes. The TME is complex …
expression in the breast TME capable of predicting clinical outcomes. The TME is complex …
Cellular senescence offers distinct immunological vulnerabilities in cancer
Chronic damage following oncogene induction or cancer therapy can produce cellular
senescence. Senescent cells not only exit the cell cycle but communicate damage signals to …
senescence. Senescent cells not only exit the cell cycle but communicate damage signals to …
Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis
MALAT1, one of the few highly conserved nuclear long noncoding RNAs (lncRNAs), is
abundantly expressed in normal tissues. Previously, targeted inactivation and genetic …
abundantly expressed in normal tissues. Previously, targeted inactivation and genetic …
First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer
R Rudalska, J Harbig, M Forster, P Woelffing… - Nature Cancer, 2025 - nature.com
Colorectal cancer (CRC) constitutes the second leading cause of cancer-related death
worldwide and advanced CRCs are resistant to targeted therapies, chemotherapies and …
worldwide and advanced CRCs are resistant to targeted therapies, chemotherapies and …
[HTML][HTML] Gram-Negative Microflora Dysbiosis Facilitates Tumor Progression and Immune Evasion by Activating the CCL3/CCL5–CCR1–MAPK–PD-L1 Pathway in …
H Yang, J Cai, X Huang, C Zhan, C Lu… - Molecular Cancer …, 2025 - aacrjournals.org
Abstract Gram-negative (G−) microflora dysbiosis occurs in multiple digestive tumors and is
found to be the dominant microflora in the esophageal squamous cell carcinoma (ESCC) …
found to be the dominant microflora in the esophageal squamous cell carcinoma (ESCC) …
Promoting longevity with less cancer: The 2022 International Conference on Aging and Cancer
Y Cui, K Wang, D Jiang, Y Jiang, D Shi… - Aging and …, 2023 - Wiley Online Library
Aging and cancer are increasingly becoming big challenges for public health worldwide due
to increased human life expectancy. Meanwhile, aging is one of the major risk factors for …
to increased human life expectancy. Meanwhile, aging is one of the major risk factors for …
[HTML][HTML] MiR-200c reprograms fibroblasts to recapitulate the phenotype of CAFs in breast cancer progression
Z Lin, ME Roche, V Díaz-Barros, M Domingo-Vidal… - Cell Stress, 2024 - ncbi.nlm.nih.gov
Mesenchymal-epithelial plasticity driving cancer progression in cancer-associated
fibroblasts (CAFs) is undetermined. This work identifies a subgroup of CAFs in human breast …
fibroblasts (CAFs) is undetermined. This work identifies a subgroup of CAFs in human breast …
[HTML][HTML] Tumor cell p38 inhibition to overcome immunotherapy resistance
JJ Luke, RE Dadey, RC Augustin, S Newman… - Research …, 2023 - ncbi.nlm.nih.gov
Patients with tumors that do not respond to immune-checkpoint inhibition often harbor a non-
T cell-inflamed tumor microenvironment, characterized by the absence of IFN-γ-associated …
T cell-inflamed tumor microenvironment, characterized by the absence of IFN-γ-associated …
[PDF][PDF] Targeting p38 MAPK Signaling to Suppress Inflammatory Tumor-Stroma-Immune Crosstalk in Pancreatic Cancer
SP Singh - 2024 - scholarship.miami.edu
Pancreatic ductal adenocarcinoma (PDAC) is characterized by uniquely desmoplastic
stroma and chronic inflammatory milieu and has posed a major therapeutic challenge due to …
stroma and chronic inflammatory milieu and has posed a major therapeutic challenge due to …